Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
118
118 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- RilvegostomigAZD2936Phase 325 trials
AstraZeneca · Biliary Tract Cancer, Gastric Cancer, Non-small Cell Lung Cancer
- AfimkibartRO7790121, RVT-3101Phase 312 trials
Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis
- AmlitelimabSAR445229Phase 39 trials
Sanofi · Dermatitis Atopic, Coeliac Disease, Celiac Disease
- CM512Phase 39 trials
Keymed Biosciences Co.Ltd · Chronic Rhinosinusitis With Nasal Polyposis, Chronic Spontaneous Urticaria (CSU), Asthma
- HSK44459Phase 39 trials
Haisco Pharmaceutical Group Co., Ltd. · Psoriasis, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis
- LunsekimigSAR443765Phase 39 trials
Sanofi · Asthma, Chronic Obstructive Pulmonary Disease, Chronic Rhinosinusitis With Nasal Polyps
- LutikizumabABT-981Phase 38 trials
AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis
- PF-07275315tilrekimigPhase 38 trials
Pfizer · Atopic Dermatitis, Asthma, Moderate to Severe Chronic Obstructive Pulmonary Disease
- SHR-1819Phase 38 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Seasonal Allergic Rhinitis, Moderate to Severe Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis
- TLL-018Phase 38 trials
Hangzhou Highlightll Pharmaceutical Co., Ltd · Chronic Spontaneous Urticaria (CSU), Rheumatoid Arthritis, Chronic Spontaneous Urticaria
- barzolvolimabCDX-0159Phase 37 trials
Celldex Therapeutics · Chronic Spontaneous Urticaria, Chronic Inducible Urticaria, Cold Urticaria
- MG-K10Humanized Monoclonal AntibodyPhase 36 trials
Shanghai Mabgeek Biotech.Co.Ltd · Dermatitis, Atopic, Chronic Urticaria, Idiopathic, Atopic Dermatitis
- SHR-1905Phase 36 trials
Guangdong Hengrui Pharmaceutical Co., Ltd · Asthma, Chronic Rhinosinusitis With Nasal Polyps, Moderate-to-severe Atopic Dermatitis
- CM310Phase 35 trials
Keymed Biosciences Co.Ltd · Atopic Dermatitis, Moderate to Severe Asthma, Chronic Obstructive Pulmonary Disease
- VC005Phase 35 trials
Jiangsu vcare pharmaceutical technology co., LTD · Non-segmental Vitiligo, Non-Segmental Vitiligo, Atopic Dermatitis
- ICP-332Phase 34 trials
Beijing InnoCare Pharma Tech Co., Ltd. · Non Segmental Vitiligo, Chronic Spontaneous Urticaria (CSU), Atopic Dermatitis
- Jaktinib HydrochloridePhase 34 trials
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Atopic Dermatitis, Ankylosing Spondylitis
- MG-K10 Humanized Monoclonal AntibodyPhase 34 trials
Shanghai Mabgeek Biotech.Co.Ltd · Atopic Dermatitis, Seasonal Allergic Rhinitis, Chronic Spontaneous Urticaria (CSU)
- RezpegaldesleukinNKTR-358, REZPEGPhase 34 trials
Nektar Therapeutics · Moderate-to-Severe Atopic Dermatitis, Moderate to Severe Atopic Dermatitis, Alopecia Areata
- LNK01001Phase 33 trials
Lynk Pharmaceuticals Co., Ltd · Ankylosing Spondylitis, Atopic Dermatitis, Rheumatoid Arthritis
- QY201Phase 33 trials
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. · Adult Subjects With Non-Segmental Vitiligo, Atopic Dermatitis (AD), Adolescent Participants With Moderate to Severe Atopic Dermatitis (AD)
- RocatinlimabAMG 451Phase 33 trials
Amgen · Atopic Dermatitis
- TQH2722Phase 33 trials
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Seasonal Allergic Rhinitis, Atopic Dermatitis
- 4-MUSTtrimebutine 4-methylumbelliferyl sulfatePhase 32 trials
Valenta Pharm JSC · Chronic Cholecystitis, Biliary Dyskinesia
- ADSTEM Inj.Phase 32 trials
EHL Bio Co., Ltd. · Atopic Dermatitis
- AK111Phase 32 trials
Akeso · Psoriasis, Skin Diseases, Ankylosing Spondylitis
- allo-APZ2-CVUSkin-derived ABCB5-positive dermal mesenchymal stromal cellsPhase 32 trials
RHEACELL GmbH & Co. KG · Venous Leg Ulcer, Skin Ulcer Venous Stasis Chronic
- allo-APZ2-OTSPhase 32 trials
RHEACELL GmbH & Co. KG · Epidermolysis Bullosa
- ASC40Phase 32 trials
Ascletis Pharmaceuticals Co., Ltd. · Acne
- BCD-217Phase 32 trials
Biocad · Melanoma Stage III, Melanoma (Skin), Melanoma
- BFB759Phase 32 trials
Bluefin Biomedicine, Inc. · Atopic Dermatitis (AD), Hidradenitis Suppurativa (HS)
- calcineurin inhibitorsPhase 32 trials
Sanofi · Dermatitis Atopic
- CMS-D001Phase 32 trials
Dermavon Holdings Limited · Moderate to Severe Plaque Psoriasis, Moderate to Severe Atopic Dermatitis
- MH004Phase 32 trials
Minghui Pharmaceutical (Hangzhou) Ltd · Vitiligo, Atopic Dermatitis (AD)
Sun Pharmaceutical Industries, Inc. · Actinic Keratosis
- SD-101 DermalPhase 32 trials
Paradigm Therapeutics · Epidermolysis Bullosa (EB)
- SoquelitinibCPI-818Phase 32 trials
Corvus Pharmaceuticals, Inc. · Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
- StapokibatrtPhase 32 trials
Keymed Biosciences Co.Ltd · Atopic Dermatitis
- TR987 0.1%Phase 32 trials
TR Therapeutics · Venous Leg Ulcer, Venous Ulcer, Venous Stasis Ulcer
- VC005 groupPhase 32 trials
Jiangsu vcare pharmaceutical technology co., LTD · Atopic Dermatitis, Moderate to Severe Atopic Dermatitis
- dabocemagene autoficelFCX-007, see below for FCX-007 descriptionPhase 31 trial
Castle Creek Biosciences, LLC. · Recessive Dystrophic Epidermolysis Bullosa
- DenifanstatPhase 31 trial
Sagimet Biosciences Inc. · Acne Vulgaris
- DMT310Phase 31 trial
Dermata Therapeutics · Acne Vulgaris
- GS101Phase 31 trial
Jiangsu Genscend Biopharmaceutical Co., Ltd · Atopic Dermatitis (AD)
- IBI3027Phase 31 trial
Innovent Biologics (Suzhou) Co. Ltd. · Atopic Dermatitis
- ipilimumab and nivolumabPhase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
- KB803Phase 31 trial
Krystal Biotech, Inc. · Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa
- LNS8801Phase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
- LW402Phase 31 trial
Shanghai Longwood Biopharmaceuticals Co., Ltd. · Moderate to Severe Atopic Dermatitis
- nivolumab and relatlimabPhase 31 trial
Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.